PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20703229-4	2010	Treatment with Ang II increased phosphorylated ERK 1/2 of SMC and EC, proliferation of SMC and adhesion of monocyte to EC, which were blocked by olmesartan.	olmesartan	145-155	mitogen-activated protein kinase 3	Homo sapiens	47-54	
17380010-7	2007	The effect of Ang II on ERK1/2 phosphorylation was blocked by Ang II type 1 receptor antagonists, RNH6270 and PD98059 but not by SB203580 or Guanosine-5"-O-(2-ThioDiphosphate), a G-protein inhibitor.	olmesartan	98-105	mitogen-activated protein kinase 3	Homo sapiens	24-30	
20508392-5	2010	Olmesartan inhibited AII-induced ERK1/2 and JNK activation at lower concentrations (10 nM).	olmesartan	0-10	mitogen-activated protein kinase 3	Homo sapiens	33-39	
20508392-8	2010	From these findings, it was inferred that angiotensin-receptor blockade by olmesartan results in the inhibition of AII-induced activation of Src, ERK1/2, and JNK in RASMC.	olmesartan	75-85	mitogen-activated protein kinase 3	Homo sapiens	146-152